Liver Cancer — Global Clinical Trial Landscape (2024)

Explore cutting-edge liver cancer research in Novotech CRO's disease report, detailing new treatments, clinical trials, and future innovations. Liver cancer, predominantly hepatocellular carcinoma, arises from chronic liver conditions and poses a significant global health burden. Surgical resection and liver transplantation offer optimal outcomes, while treatment options include chemotherapy, monoclonal antibodies, small molecules, and immunotherapies.
With over 1,700 liver cancer trials initiated since 2018, Asia-Pacific and North America lead in research efforts, reflecting diverse global epidemiological trends and ongoing advancements in therapeutic strategies.
Discover more in Novotech's comprehensive disease report on liver cancer.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.